EVALUATION OF MARKETED KITS FOR MEASUREMENT OF ABP 501, THE FIRST APPROVED ADALIMUMAB BIOSIMILAR, DRUG CONCENTRATION AND ANTI-DRUG ANTIBODY LEVELS IN PATIENT SERUM

被引：0

作者：

Mytych, Dan ^{[1
]}

Manning, Marta Starcevic ^{[1
]}

Colbert, Alexander ^{[1
]}

Hoofring, Sarah ^{[1
]}

Miller, Jill ^{[1
]}

Gessner, Melissa ^{[1
]}

Chow, Vincent ^{[1
]}

Fanjiang, Gary ^{[1
]}

机构：

[1] Amgen Inc, Thousand Oaks, CA USA

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷

关键词：

D O I：

10.1136/annrheumdis-2019-eular.6361

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

FRI0645

引用

页码：1020 / 1020

页数：1

共 49 条

[21] IMPACT OF ADALIMUMAB SERUM CONCENTRATION ON EFFICACY AND ASSOCIATION BETWEEN ANTI-DRUG ANTIBODIES AND SERUM CONCENTRATION: 24 WEEK RESULTS FROM A PHASE III STUDY COMPARING SB5 (AN ADALIMUMAB BIOSIMILAR) WITH REFERENCE ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS [J].

Kay, J. ;

Weinblatt, M. ;

Keystone, E. ;

Genovese, M. ;

Ghil, J. ;

Cheong, S. Y. ;

Hong, E. E. .

ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 :136-136

[22] Comparison study of two commercially available methods for the determination of infliximab, adalimumab, etanercept and anti-drug antibody levels [J].

Ruiz-Argueello, Begona ;

del Agua, Ainhoa Ruiz ;

Torres, Nerea ;

Monasterio, Alberto ;

Martinez, Antonio ;

Nagore, Daniel .

CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2013, 51 (12) :E287-E289

[23] Significance of measurement of serum trough level and anti-drug antibody of adalimumab as personalised pharmacokinetics in patients with Crohn's disease: a subanalysis of the DIAMOND trial [J].

Nakase, H. ;

Motoya, S. ;

Matsumoto, T. ;

Watanabe, K. ;

Hisamatsu, T. ;

Yoshimura, N. ;

Ishida, T. ;

Kato, S. ;

Nakagawa, T. ;

Esaki, M. ;

Nagahori, M. ;

Matsui, T. ;

Naito, Y. ;

Kanai, T. ;

Suzuki, Y. ;

Nojima, M. ;

Watanabe, M. ;

Hibi, T. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (09) :873-882

[24] Analysis of Anti-drug Antibodies (ADA) to Adalimumab in Patient Serum Using a Novel Homogeneous Mobility Shift Assay [J].

Wang, Shui Long ;

Ohrmund, Linda ;

Ling, Nicholas ;

Singh, Sharat .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 :S444-S445

[25] PROACTIVE MONITORING OF INFLIXIMAB (IFX) AND ADALIMUMAB (ADA) DRUG AND ANTI-DRUG ANTIBODY CONCENTRATION UTILIZING THE LABCORP ASSAY IN INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS [J].

Perinbasekar, Rajiv A. ;

Brown, Sara A. ;

Syed, Nauroz ;

Lonsako, Shumet ;

Cross, Raymond K. .

GASTROENTEROLOGY, 2017, 152 (05) :S392-S392

[26] METHOD COMPARISON STUDY OF ASSAYS FOR THE DETERMINATION OF INFLIXIMAB, ADALIMUMAB, AND ANTI-DRUG ANTIBODY LEVELS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES [J].

Nagore, D. ;

Ruiz del Agua, A. ;

Pascual, J. ;

Llinares-Tello, F. ;

Herreros, B. ;

Martinez, A. ;

Martin, S. ;

Navarro, R. ;

del Rio, L. .

GUT, 2015, 64 :A99-A100

[27] Measurement of Anti-TNF Agents and Anti-Drug Antibodies Serum Levels in Patients with Inflammatory Bowel Disease [J].

Guerra, Ivan ;

Chaparro, Maria ;

Bermejo, Fernando ;

Gisbert, Javier P. .

CURRENT DRUG METABOLISM, 2014, 15 (09) :875-881

[28] Development and validation of enzyme-linked immunosorbent assays for the measurement of infliximab and anti-drug antibody levels [J].

Xiang, Dong ;

Li, Ninghong ;

Liu, Lu ;

Yu, Hengyi ;

Li, Xiping ;

Zhao, Tinghui ;

Liu, Dong ;

Gong, Xuepeng .

HELIYON, 2023, 9 (11)

[29] Comparison of Homogeneous Mobility Shift Assay and Solid Phase ELISA for the Measurement of Drug and Anti-Drug Antibody (ADA) Levels in Serum From Patients Treated With Anti-TNF Biologics [J].

Hauenstein, Scott ;

Ohrmund, Linda ;

Salbato, Jared ;

Reddy, Rukmini ;

McCowen, Kevin ;

Monk, Patrick ;

Lockton, Steven ;

Wang, Shui-Long ;

Singh, Sharat .

GASTROENTEROLOGY, 2012, 142 (05) :S538-S538

[30] Serum drug levels and anti-drug antibodies in the context of dose tapering by interval prolongation of adalimumab, etanercept and ustekinumab in psoriasis patients: results of the CONDOR trial [J].

Atalay, Selma ;

Berends, Sophie E. ;

Groenewoud, Hans M. M. ;

Mathot, Ron A. A. ;

Njoo, David M. ;

Mommers, Johannes M. ;

Ossenkoppele, Paul M. ;

Koetsier, Marjolein I. A. ;

Berends, Maartje A. ;

de Vries, Annick ;

van de Kerkhof, Peter C. M. ;

den Broeder, Alfons A. ;

de Jong, Elke M. G. J. ;

van den Reek, Juul M. P. A. .

JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (05) :2680-2684

← 1 2 3 4 5 →